NIA's #1 favorite AI stock suggestion Healwell AI (TSX: AIDX) partnered with Takeda (TAK) last week a US$42 BILLION market cap company.
AIDX's Pentavere and its best-in-class AI engine DARWEN is changing the world!
AIDX and TAK will drive real-world evidence analysis for rare diseases, particularly focusing on supporting patients suffering from hereditary angioedema (HAE) with normal C1 inhibitor across Canada. HAE with normal C1 inhibitor is an ultra-rare disease characterized by life-threatening recurrent, unpredictable swelling, and currently does not have any approved treatments.
Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. NIA has received compensation from AIDX of US$50,000 cash for a six-month marketing contract. This message is meant for informational and educational purposes only and does not provide investment advice.
Preparing Americans for Hyperinflation
